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Abstract We investigated 38 cases of B-cell chronic lympho-
cytic leukemia (B-CLL) for the presence of non-productive
rearrangements in the SW regions and defined for the first time
the molecular nature of these rearrangements. Southern blot
analysis revealed SW region rearrangements in 13 cases (34%)
and polymerase chain reactions (PCRs) indicated that these
rearrangements consisted of internal deletions of the SW region.
Long-distance PCRs localized the SW deletions in the VHDJH
rearranged allele in most cases. We investigated if SW deletions
were related to VH somatic mutations that, together with isotype
switch recombination, are indicative of the B-cell maturation
stage. No significant correlation between the presence of SW
deletions and VH somatic mutations was found, indicating that
the two processes are independent in B-CLL. Moreover no
significant correlation between SW deletions and prognosis was
observed. Having shown that SW internal deletions are not
chromosome translocations rules out their involvement in the
onset of malignancy, while their localization in the VHDJH
rearranged alleles suggests a possible role in the stabilization of
the isotype of the expressed immunoglobulin. ß 2002 Published
by Elsevier Science B.V. on behalf of the Federation of Euro-
pean Biochemical Societies.
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1. Introduction
B-cell chronic lymphocytic leukemia (B-CLL) is the most
frequent form of adult leukemia, accounting for 30% of all
leukemias. This leukemia is characterized by accumulation of
monoclonal B-cells, with the appearance of small CD5 and
CD23 mature lymphocytes [1,2]. Based on these character-
istics, it had been suggested that B-CLL is a tumor of ‘naive’
B-cells possibly arising in the follicular mantle zone [3]. How-
ever, some B-CLL with somatically mutated immunoglobulin
(Ig) variable genes have been described [4]. Since somatic mu-
tation is believed to occur in germinal centers [5], the presence
of such mutations indicates that the cell of origin has passed
through the germinal center. Thus, it has been suggested that
B-CLL comprises two di¡erent disease subtypes, one arising
from a ‘naive’ B-cell, the other from a ‘memory’ B-cell [6].
Interestingly, patients with non-mutated variable genes have a
distinctly more malignant disease and a much shorter survival
than those with somatic mutations [6,7].
Under physiological conditions, somatic mutation of the
variable genes occurs in temporal correlation with isotype
switching in the germinal center microenvironment [8,9] and
the recent discovery of AID (activation-induced cytidine de-
aminase) [10] has revealed an unexpected link between isotype
switch recombination and somatic hypermutation.
However B-CLL cells express mostly surface Igs of the IgM
or IgM/IgD isotype and only a small proportion of B-CLL is
characterized by the expression of isotype-switched Igs [1,2].
Two studies reported the presence of isotype-switched tran-
scripts in B-CLL patients [11,12] and the ability of B-CLL to
proliferate and di¡erentiate into Ig-secreting cells after in vitro
stimulation has been described [2,13,14]. The major mecha-
nism for isotype switching is a deletional recombination be-
tween switch regions, which are highly repetitive regions up-
stream of each cluster of constant genes, except for N [15].
Rearrangements in the Ig SW regions without isotype switch-
ing have been previously observed in B-CLL cases but the
molecular nature and the clinical implications of these alter-
ations were not investigated [16,17]. We analyzed 38 cases of
B-CLL to de¢ne the molecular nature of the SW region rear-
rangements, their relation to variable genes mutations and to
clinical course.
2. Materials and methods
2.1. B-CLL patients, phenotypic characterization and disease course
Forty patients with clinical features of B-CLL were randomly chos-
en among a series of 145 cases. Peripheral blood of these patients
revealed expansion of cells with the typical phenotype of B-CLL
(CD5/CD19, CD23, CD223, low or absent CD79b expression).
The disease course was assessed clinically considering the following
criteria recommended in the National Cancer Institute sponsored
workshop in 1996 [18]: blood cell counts (percentage of neoplastic
CD5/CD19 cells), lymphocyte count doubling time, progression
to a more advanced stage of disease, development of systemic symp-
toms and a downward trend of hemoglobin or platelet count. The
presence of at least one altered feature was su⁄cient to de¢ne ‘pro-
gressive disease’ ; patients without altered features were designated as
having ‘stable disease’.
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2.2. Southern blot analysis
Digested genomic DNA was fractionated by gel electrophoresis on
a 0.8% agarose gel, denatured with 0.5 N NaOH/1.5 M NaCl, neu-
tralized with 1 M Tris^HCl/1.5 M NaCl, and transferred overnight to
nylon ¢lters with 20U SSC. The following day, ¢lters were air-dried
and ¢xed with UV light (UV Stratalinker).
2.3. Probes
The SW region was analyzed using two cbP radiolabeled 5PSW and
3PSW probes localized upstream and downstream of the SW region,
respectively. Probes were synthesized by polymerase chain reaction
(PCR) using speci¢c oligonucleotides reported elsewhere [19].
2.4. Hybridization conditions
Filters were hybridized overnight at 42‡C in hybridization bu¡er
(1 M NaCl, 50 mM Tris^HCl pH 7.4, 40% formamide, 10% dextran
sulfate, 1% SDS and 100 Wg/ml salmon sperm DNA) and 2U106 cpm/
ml of probe. Filters were washed sequentially in solutions containing
2USSC/0.1% SDS (room temperature), 1USSC/0.1% SDS (42‡C) and
0.1USSC/0.1% SDS (65‡C), exposed overnight, and scanned on a
phosphorimager.
2.5. PCR of SW regions
Genomic DNA (100 or 300 ng) was used as template in PCR re-
actions with several oligonucleotides (Fig. 1). The reaction mixture
contained dNTPs at 200 Wmol/l, primers at 0.2 Wmol/l, 1 U rTth
polymerase (Perkin Elmer) and Mg(OAc)2 at 1.2 mmol/l, in a ¢nal
volume of 25 or 50 Wl. PCR cycles were: one cycle at 94‡C for 3 min,
34 cycles at 94‡C for 1 min, 62‡C for 1 min and 70‡C for 5 min and a
¢nal step at 70‡C for 10 min. The enzyme was added after the ¢rst
cycle (Hot Start procedure).
2.6. PCR of VH DJH regions
Genomic DNA (1 Wg) was PCR-ampli¢ed using two consensus
primers: FR1c, complementary to framework 1, and JHc, comple-
mentary to the joining segment (Fig. 1). PCR was performed in a
¢nal volume of 50 Wl, with 50 pmol of each primer, 200 WM dNTPs,
1 mM MgCl2, 10% of DMSO and 1 U Taq DNA polymerase (Gibco).
Ampli¢cation consisted of an initial denaturation step at 94‡C for
3 min followed by 34 cycles at 94‡C for 1 min, at 62‡C for 1 min
and 72‡C for 2 min, with a ¢nal extension step for 10 min at 72‡C.
2.7. VH DJH and SW sequence analysis
The VHDJH sequence of each patient was analyzed using the Ig-
BLAST database to identify the germline sequence with highest ho-
mology, followed by alignment to its closest germline to detect muta-
tions. Based on the number of somatic mutations detected in these
genes, the cases were classi¢ed as ‘unmutated’ or ‘mutated’. Consis-
tent with current convention, ‘unmutated’ genes were de¢ned as those
with 6 2% di¡erences from the most similar VH germline, while ‘mu-
tated’ genes were those with v 2% di¡erence from the closest germ-
line. PCR-ampli¢ed SW regions were aligned to the germline sequences
HSIMMDL^HSJHCMU using the BLAST database to identify dele-
tions and/or DNA rearrangements.
2.8. PCR from the VH DJH to the SW region
Genomic DNA (100 ng) of each patient with SW rearrangements
was ampli¢ed using a ‘touchdown’ strategy. Forward primers anneal-
ing to the speci¢c VH family expressed by each case were used in
combination with a reverse primer complementary to the 3P of the
SW region (3MRA or 3MRB) (Fig. 1). PCR reaction was performed in
a ¢nal volume of 100 Wl with 20 pmol of each primer, 200 WM of
dNTPs, 1.2 mM of Mg(OAc)2 and 2 U of rTth DNA polymerase (PE
Applied Biosystem) with the Hot Start technique. Ampli¢cation con-
sisted of an initial denaturation step of 1 min at 94‡C followed by 24
cycles at 94‡C for 15 s and 68‡C for 10 min with an increasing time of
15 s in the last 10 cycles. The ¢nal extension step was performed at
72‡C for 10 min.
2.9. Statistical analysis
Statistical analyses were performed with the Fisher’s Exact Test.
3. Results
3.1. Southern blot and PCR analysis of SW regions in
B-CLL cases
Forty B-CLL patients were initially screened for Ig isotype;
28 had IgM B-leukemic cells, eight had IgM/IgD, two
IgG, one IgD and one had non-producing cells. DNA
from peripheral blood lymphocytes of the 38 patients with
‘unswitched’ isotype, i.e. no evidence of productive isotype
switch, was extracted and analyzed by Southern blot using
two probes localized upstream (5PSW) and downstream
(3PSW) of the SW region [19] (Fig. 1A). If the cell does not
undergo isotype switch recombination, its switch regions are
in germline con¢guration and the 5PSW and 3PSW probes cohy-
bridize to a fragment of a given length. If the cell undergoes a
physiological isotype switch recombination, the 5PSW probe
cohybridizes with the 3P switch probe of the correspondent
isotype. If the switch recombination is ‘aberrant’, the 5PSW
Table 1
Southern blot and PCR results for the 13 cases with SW rearrangements
Case Rearranged fragments size (kb)a PCR fragments size (kb) Primer pairs PCR deletion size (kb)
5PSW 3PSW
1 8 8 3 5MFA/3MRA 0.9
2 8.5 8.5 3.5 5MFA/3MRA 0.4
3 7 7 1.8 5MFA/3MRA 2.1
7.5 2.5 5MFB/CmR1 1.6
4 5.2 5.2 1.25 5PcWF/3MRB 3.75
8
5 7.5 7.5 2.5 5MFA/3MRA 1.4
7 7.2 7.2 2.3 5MFA/3MRA 1.6
18 6 6 2.5 5PcWF/3MRB 2.6
8
20 8.5 8.5 3.5 5MFA/3MRA 0.4
6.5
27 6.4 6.4 1.5 5MFA/3MRA 2.5
31 6.4 6.4 1 and 0.8 5MFA/3MRA and 5MFB/3MRB 2.8
6 6 0.4 5MFB/3MRB 3.2
35 6.1 6.1 0.9 5MFA/3MRA 2.9
36 5.5 1.9 5PcWF/3MRB 3.2
40 8.5 8.5 3.5 5MFA/3MRA 0.5
aOnly rearranged fragments smaller than the germline are indicated.
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probe does not cohybridize to any downstream 3P switch
probe.
On SphI digestion, DNA from 25 of the 38 patients showed
a SW region in germline con¢guration, while the remaining 13
patients showed additional rearranged bands (Fig. 2). Hybrid-
ization with the 5PSW probe, revealed seven cases (1, 2, 5, 7,
27, 36, 40) with one rearranged band and six cases (3, 4, 18,
20, 31, 35) with two rearranged bands. With the 3PSW probe,
10 cases (1, 2, 3, 4, 5, 7, 18, 20, 27, 40) presented one rear-
ranged band and three cases presented two rearranged bands
(31, 35, 36). Interestingly, in all but two (35, 36) of these cases,
the rearranged fragments identi¢ed by the 5P and 3PSW probes
cohybridized and were about 0.5^4 kb smaller than the germ-
line fragment. The di¡erent sizes of the rearranged bands
(Table 1) excluded the possibility that they were polymorphic
alleles while the cohybridization of the two SW probes sug-
gested an internal deletion in the SW region [20,21].
Indeed PCR using primers 5MFA/3MRA or additional
primer pairs located upstream and downstream to 5MFA/
3MRA (Fig. 1B) indicated the presence of deletions in the
SW regions. In all 13 cases with SW rearrangements, a band
of reduced size compared to the germline was ampli¢ed (Fig.
3). Cases in Fig. 3A were ampli¢ed with primers 5MFA/
3MRA, which amplify a fragment of 3.9 kb when the SW
region is in germline con¢guration, whereas the cases in Fig.
3B were ampli¢ed with primers 5PcWF/3MRB, which amplify
a 5.1 kb fragment when the SW region is in germline con¢g-
uration. In three cases (20, 35, 40), PCR ampli¢cation pro-
duced very faint bands (data not shown). In all cases, the
reduction in size of the PCR-ampli¢ed products corresponded
to the reduction observed for the rearranged bands in South-
ern blot (Table 1). Bands that on Southern blot were larger
than the germline might contain a restriction site polymor-
phism or may be generated by insertions [22], or by inversions
[23].
Sequencing of the PCR-ampli¢ed fragment from case 4
con¢rmed the presence of SW deletion. This case showed the
germline bands and two rearranged bands of 8 kb and 5.2 kb
with the 5PSW probe and one rearranged band of 5.2 kb with
the 3PSW probe (Fig. 2). No reduced size bands were ampli¢ed
with primers 5MFA/3MRA, whereas primers 5PcWF/3MRB
ampli¢ed a 1.25 kb band (Fig. 3B). The sequence of the
1.25 kb band (Fig. 4) showed a germline con¢guration from
the 5PcWF position in HSIMMDL (90885) to position 92021.
After the breakpoint (ending at position 3671 in HSJHCMU),
the sequence continued until position 3803 in HSJHCMU
(3MRB position). Thus, a 3.75 kb deletion occurred on this
allele between position 92021 in HSIMMDL and position
3671 in HSJHCMU. Additional PCRs did not amplify any
product from the other allele, which might be involved in a
translocation, or any other chromosomal rearrangement.
Fig. 1. A: Localization of the SW probes used for Southern blot as-
say and of the primers used for PCR ampli¢cation of IgH SW re-
gions. B: Primer sequences and relative position in GenBank data-
base.
Fig. 2. Southern blot analysis of SW regions in B-CLL patients. Ge-
nomic DNA of B-CLL patients was digested with SphI restriction
enzyme, electrophoresed, blotted and probed sequentially with 5PSW
(5P) and 3PSW (3P) probes. The hybridization pattern of 13 cases
with rearranged SW bands and one case (#32) in germline con¢gura-
tion is shown. PC = placental genomic DNA used as germline con-
trol.
Fig. 3. PCR ampli¢cation of the SW region in patients with SW rear-
ranged bands. A: Ampli¢cation of seven B-CLL cases with 5MFA/
3MRA primer pair. B: Ampli¢cation of three cases with 5PcWF/
3MRB primer pair.
Fig. 4. Graphic representation of the breakpoint present in the SW
fragment of case 4. The fragment was PCR-ampli¢ed using the
5PcWF/3MRB primer pair. EW= IgH enhancer; SW= switch mu re-
gion, HSIMMDL = GenBank DNA sequence of the human IgD seg-
ment locus, HSJHCMU = GenBank nucleotide sequence of the IgH
SW region.
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3.2. Localization of SW deletions in the VH DJH rearranged
allele
SW deletions could stabilize the isotype of the expressed Ig
only if they occurred on the VHDJH rearranged allele. To
de¢ne the localization of SW deletions we ampli¢ed cases
with SW deletions with primers in the VH region and in the
3P part of the SW region (Fig. 1A). Sizes of the VHDJH rear-
ranged fragments varied on the presence or absence of the SW
deletion, being smaller the allele with the VHDJH rearrange-
ment and SW deletion. Using long-distance PCR conditions, it
was possible to amplify the allele with the VHDJH rearrange-
ment and SW deletion in eight out of 13 cases (Fig. 5). In only
one case (#7) the SW deletion occurred on the unrearranged
allele. Case 12, that presents a VHDJH rearranged allele with-
out SW rearrangements, was used as control. We were not able
to amplify by long-distance PCR the remaining four cases.
3.3. Analysis of somatic mutations in the variable genes
DNA of the 38 patients was then analyzed for the presence
of somatic mutations in the variable heavy chain (VH) genes.
Ampli¢cation of the VH genes using consensus primers in the
framework 1 region (FR1c) and in the joining heavy chain
region (JHc) resulted in a PCR fragment of about 350 bp.
The number of somatic mutations was determined by compar-
ing the VH sequences to the germline genes with the highest
homology. Sixteen cases expressed VH1 family genes, 14 cases
VH3, ¢ve cases VH4, two cases VH2, and one case expressed
both VH1 and VH3. Somatic mutations ranging from 2.3% to
11.6% were observed in 16 cases while the leukemic cells of 21
patients had VH genes with v 98% sequence homology with
the nearest germline gene. In the remaining case presenting a
productive rearrangement of both variable regions, a VH1^2
in germline con¢guration and a VH3^48 in mutated form was
observed. No correlation between the presence of SW rear-
ranged bands and VH gene mutations was observed, since
four of 13 cases (32%) with a deletion in the SW region showed
VH mutations, and 13 of 25 of cases (52%) without deletion in
the SW showed VH mutations (P = 0.13).
3.4. Clinical observations
The clinical course of 22 patients with a follow-up period of
at least 5 years was correlated with the presence of SW rear-
ranged bands and VH mutations. The presence of switch re-
arrangements alone was not indicative of the clinical course.
Indeed, out of eight cases with switch rearrangements ¢ve
underwent disease progression (62.5%) whereas out of 14
cases without switch rearrangements six underwent progres-
sion (42.8%) (P = 0.24). On the contrary, the presence of VH
mutations was indicative of the clinical course. Out of 11 cases
with VH mutations only three cases were in progression
(27.2%) whereas out of 11 cases without VH mutations eight
cases (72%) were in progression (P = 0.04).
4. Discussion
Southern blot analysis of 38 B-CLL cases with IgM or IgM/
IgD phenotype revealed rearrangements in the Ig SW region in
13 cases (34%), although no correlation between SW rearrange-
ments and Ig phenotype (IgM only or IgM/IgD) was found.
We show here for the ¢rst time that most of these SW region
rearrangements, previously observed in B-CLL by other in-
vestigators [16,17,23], are genomic deletions of the SW region
occurring in most cases in the VHDJH rearranged allele. These
deletions are of variable length, ranging from 0.5 kb to about
4 kb and may involve the region upstream or downstream the
SW region but never the constant W exons. The random dis-
tribution of these deletions might be related to the absence of
a consensus-cutting site inside the SW region [24,25]. The fre-
quent localization of SW deletions within the VHDJH rear-
ranged allele would suggest that B-CLL cells have undergone
this partial deletion of the SW region in order to stabilize the
isotype of the expressed Ig [20,21]. Indeed, although it was
demonstrated that the Ig heavy chain intronic enhancer is
necessary and su⁄cient to promote class switch recombina-
tion, a deletion of the SW tandem repeats in the mouse Ig
heavy chain locus reduces the e⁄ciency of class switching
[26]. This event would allow the W heavy chain-producing cells
to continue producing IgM [21].
We then investigated if SW deletions were related to VH
somatic mutations, a marker of the B-cell maturation stage.
Sequencing of the VH regions of all 38 cases indicated the
presence of somatic mutations in 17 cases (44.7%). No corre-
lation between the presence of SW deletions and VH gene mu-
tations was observed, since 32% of cases with a deletion in the
SW region showed VH mutations, and 52% of cases without
deletion in the SW showed VH mutations. Therefore, it seems
that SW internal deletions might occur independently of the
B-cell maturation stage. Moreover, while a correlation of VH
mutations with disease progression was detected, con¢rming
recent data on the possible use of VH status as a prognostic
factor [6], SW rearrangements alone did not appear to be in-
dicative of clinical course.
SW internal deletions might represent ‘failed switching at-
tempts’, as suggested by Q. Pan et al., who frequently detected
internal deletions in the SW, SQ4 and SQ3 regions [27]. How-
ever, the frequent localization of SW internal deletions in the
VHDJH rearranged allele supports the hypothesis that SW in-
ternal deletions do not occur randomly, but have a precise
role in stabilizing the isotype of the expressed Ig. Possibly,
‘failed switching attempts’ may themselves contribute to iso-
type stabilization. This mechanism can explain why only a
small proportion of B-CLL cells undergo isotype switch and
might be of great interest to fully understand the process of
isotype switching in this leukemia. It is unknown if SW dele-
tions occur in a B-cell before or after malignant transforma-
tion; however, having shown that these rearrangements are SW
internal deletions and not chromosome translocations rules
out their involvement in the onset of malignancy.
Fig. 5. Ampli¢cation of VHDJH rearranged allele in B-CLL cases.
VHDJH rearranged allele was ampli¢ed using a forward primer an-
nealing to a variable region in combination with a reverse primer
speci¢c for the 3PSW region. Case 12, that did not present rearrange-
ments in the SW region, was used as control.
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